IRulya Therapeutics Inc. vs Pharmicell Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmicell Co., Ltd. is the larger company by market value: $514 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | IRulya Therapeutics Inc. IRLA · #14,231 in the world | Pharmicell Co., Ltd. 005690.KS · #12,422 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇰🇷 South Korea |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $343 M | $514 M |
| Net income | $-84 M | — |
| Employees | 55 | — |
| Valuation | ||
| Free cash flow yield | -12.2% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, IRulya Therapeutics Inc. or Pharmicell Co., Ltd.?
Pharmicell Co., Ltd. is the larger company by market value: $514 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
More about IRulya Therapeutics Inc.
More about Pharmicell Co., Ltd.
Sources#
Every figure on this page comes from these, with the date shown next to it.